AGE RELATED NEURODEGENERATIVE DISEASES IN MICRONESIA
AGE RELATED NEURODEGENERATIVE DISEASES IN MICRONESIA
批准号:
6163783
负责人:
DOUGLAS R GALASKO
金额:
$183.35万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-01 至 2002-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Amyotrophic lateral sclerosis (ALS), parkinsonism-dementia complex
(PDC), and dementia, assumed to be a single disease entity, are highly
prevalent, age-related neurodegenerative disorders among the people of
Guam. Characteristically all show neuronal loss in the substantia nigra
and/or anterior horn cells and severe hippocampal and neocortical
neurofibrillary tangle formation. The tangles are identical to those
encountered in Alzheimer disease (AD). Thus, clinically and
pathologically this disease shows many aspects of the three major age-
related neurodegenerative disorders encountered elsewhere in the world
(ALS, AD, and Parkinson disease). Contrary to what has been reported, -
the disease is not disappearing. Currently over 200 cases of ALSIPDC are
in the Guam Patient Registry among an atrisk population of 17,000
individuals. However, the characteristics of the epidemic have changed.
Fewer cases of ALS are seen, a greater proportion of patients present
with presenile dementia, and the age of onset of necrologic impairment
has increased by about 10 years. These changes support an environmental
hypothesis with declining exposure, but other studies strongly suggest
that an inherited gene(s) defect plays a significant role in
susceptibility to this disease. The most likely model is that a gene-
environment-interaction is responsible for ALS/PDC and dementia. The
proposed program project, using epidemiologic, genetic, pathologic, and
molecular biologic approaches, address i three major issues, 1) relevant
genetic and environmental risk factors, 2) the pathogenesis and
development of tau pathology, and 3) the potential role of oxidative
stress and mitochondrial dysfunction. An important aspect involves the
recognition that many relatively young Chamorros who die without a
clinical diagnosis of ALSfPDC, show neuropathologic changes typical of
ALS/PDC. This suggests that they have yet to accumulate a sufficient
lesion burden to show clinical symptomatology. The study of brains of
such individuals provides a truly unique opportunity to identify and
characterize relevant pathogenetic features which are operative in the
earliest phases of the disease. The proposed research will provide
critical insights into the etiology and pathogenesis of this major
public health problem for the people of Guam, while also serving as a
model for the study of analogous conditions seen elsewhere in the world.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
-
批准号:10335246
-
项目类别:
-
资助金额:$252.2万
-
财政年份:2021
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Clinical Core
-
批准号:10407979
-
项目类别:
-
资助金额:$114.83万
-
财政年份:2019
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Clinical Core
-
批准号:10615163
-
项目类别:
-
资助金额:$99.71万
-
财政年份:2019
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's Disease
-
批准号:10407966
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2018
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's Disease
-
批准号:10153614
-
项目类别:
-
资助金额:$78.98万
-
财政年份:2018
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:10673098
-
项目类别:
-
资助金额:$212.77万
-
财政年份:2016
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:10531287
-
项目类别:
-
资助金额:$209.1万
-
财政年份:2016
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Core A: Administrative Core
-
批准号:8676141
-
项目类别:
-
资助金额:$66.81万
-
财政年份:2014
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Clinical Core
-
批准号:8676142
-
项目类别:
-
资助金额:$92.69万
-
财政年份:2014
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Translational Center for Alzheimer's Disease Target and Drug Discovery
-
批准号:8849662
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2014
-
负责人:DOUGLAS R GALASKO
-
依托单位:
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD
-
批准号:7197191
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2006
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:7112234
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:6804444
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:6940622
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:6725034
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:7277121
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
CLINICAL STUDIES OF NSAIDSs AS y-SECRETASE MODULATORS IN ALZHEIMER'S DISEASE
-
批准号:7568359
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2002
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:8051780
-
项目类别:
-
资助金额:$293.08万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
CORE---ADMINISTRATIVE, DATABASE, AND STATISTICAL
-
批准号:6481377
-
项目类别:
-
资助金额:$17.79万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:7210679
-
项目类别:
-
资助金额:$267.96万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
海外基金